Peer-Reviewed Study Validates Mentavi’s Online ADHD Diagnostic Evaluation in The Journal of Clinical Psychiatry

GRAND RAPIDS, Mich., September 11, 2025 — Mentavi Health announced that its landmark, real-world validation study of the Mentavi Diagnostic Evaluation has been published in the peer-reviewed Journal of Clinical Psychiatry (JCP), a widely read and respected journal. The open-access article demonstrates that Mentavi’s asynchronous, online evaluation is as accurate as a traditional face-to-face clinical interview in the diagnosis of attention-deficit / hyperactivity disorder (ADHD) in adults and provides the first peer-reviewed evidence base for a fully digital diagnostic pathway for adult ADHD. The article posted on Psychiatrist.com at 8:00 am Central time on September 8, 2025 (see link and DOI below).

Key findings from the study1

  • n = 345 adults seeking web-based ADHD assessment (predominantly female; mean age = 35).
  • Sensitivity = 80.6% and Positive Predictive Value = 94.9%
  • False-positive rate = 12% versus 56% for the in-person clinical interview, indicating the online tool is accurate in diagnosing ADHD in adults
  • Note: the full article is freely available via JCP (DOI below).

Executive comments

“Publication in a top-tier peer-review journal moves this evidence base forward, for our diagnostic evaluation specifically and for telehealth in general,” said Barry K. Herman, MD, MMM, Chief Medical Officer at Mentavi Health and first author of the paper. “The study shows that an online ADHD diagnosis can be accurately assessed asynchronously, closing gaps in care created by specialist shortages and long waitlists.”

“This study shows that online, asynchronous ADHD assessments can match the rigor of traditional interviews while expanding access for adults who face long wait times,” said Andrew J. Cutler, MD, Chief Medical Officer at Neuroscience Education Institute and Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University, and study co-author. “It demonstrates accuracy, reduces concerns about overdiagnosis, and advances evidence-based care for underserved groups.”

“Publication in JCP sets a new standard for evidence-based digital mental health,” added Keith Brophy, CEO of Mentavi Health. “It validates years of work to build the most rigorous online diagnostic platform and expands our mission to remove barriers of access to accurate mental-health assessments.”

Study design

The prospective, real-world observational study compared the Mentavi Diagnostic Evaluation—a self-paced, asynchronous questionnaire interpreted by a doctorate-level psychologist—with a structured face-to-face clinical interview conducted via video. Primary endpoints were sensitivity, specificity, and positive predictive value relative to DSM-5 criteria. The protocol was IRB-approved and powered to detect ≥80 % sensitivity with 95 % confidence.

Clinical and Public-Health Implications

  • Pent-up demand: An estimated 17 million American adults have ADHD, yet waiting lists for specialist evaluation can exceed six months.
  • Telehealth preference: CDC data indicate 46% of U.S. adults with ADHD already use telehealth services. Until now, no online assessment had been validated.
  • Health-equity impact: Digital, asynchronous tools remove geographic and scheduling barriers, enabling evidence-based diagnosis for rural, underserved, and shift-working populations.

Article details (for authors)

About Mentavi Health

Established as ADHD Online in 2018, Mentavi Health has evolved to encompass a broader range of mental health services. With the mission to make high-quality ADHD assessments accessible to all, Mentavi has grown to address not only ADHD but also the most common related mental health conditions. The nationwide Mentavi Mental Health Diagnostic Evaluation and various treatment options showcase the company’s commitment to providing comprehensive, accessible, compliant online mental health care. For more information, visit mentavi.com.

Media contact

Tim Cox, ZingPR for Mentavi Health
[email protected] 


1 Additional statistics, subgroup analyses, and methodological details are available in the open-access article (Journal of Clinical Psychiatry, on September 8, 2025 (J Clin Psychiatry 2025;86(3):25m15846; doi:10.4088/JCP.25m15846).

The Expert Mental Health Care You Need Now

From ADHD to anxiety and beyond—we can help.
Start Your Assessment

Learn About ADHD Services in Your State

Live your best life with ADHD

Learn more about the three steps to Medical Treatment for ADHD
3 Simple Steps

More than ADHD?

From anxiety and depression to binge eating and obsessive compulsive disorder, ADHD rarely operates alone. Our Mentavi Diagnostic Evaluation screens for common comorbidities.
Learn More
Explore More

Quintessence Psychiatry Adopts Mentavi’s Mental Health Diagnostic Evaluation to Offer More Rigorous, Timely ADHD Assessments in Private Practice

Higher-Education Institutions Turn to Mentavi Health to Reduce Diagnostic Delays and Support Student Success

Mentavi Health CEO to Spotlight Trust and Validation at Tech Week Grand Rapids 2025

Articles

The constant present: Time blindness and ADHD

“Where did the time go?” It’s a question that everyone asks from...
Podcasts

Part Two: ADHD and Time Blindness with Dr. Ari Tuckman

Today, we’re continuing our conversation with Dr. Ari Tuckman, exploring...
Webinars

Mentavi Holiday Mental Wellness Series

Join us to find calm in the chaos and build...

Curious about stimulant or non-stimulant approaches?

If you’re navigating ADHD or other mental health challenges, you have options. At Mentavi Health / ADHD Online, we assess what works for you. 
Some may start with non-medicated approaches like coaching or therapy.  In other cases, patients may explore medication treatment paths when warranted by diagnosis. For some diagnosed with ADHD, the treatment clinician may work with the patient to determine if stimulant approaches work best for them. Stimulant approaches are certain medications under medical treatment that are generally Class II controlled substances. Non-stimulant options are another approach that can work for many.  Medication approaches can be used in tandem with coaching or therapy. 
 
The key is starting with our diagnostic evaluation, which is reviewed by a qualified healthcare professional. Getting clarity on what you’re experiencing is the first step toward feeling more in control. From there, you and your treatment team can determine the best path—whether that’s coaching, therapy, medication, or a combination that works for your life. 
 
If you’re not feeling right, let us walk alongside you by starting with the diagnostic evaluation.
There may be a brief delay in service today between 12:30 PM and 1:30 PM ET. Thank you for your patience — we look forward to assisting you shortly.
 
The ADHD Online Team

Join Our ADHD Research Study

Mentavi Health is conducting ADHD research and is accepting a limited number of participants. Participants in our clinical study will get an ADHD Assessment at no cost. 

Who can join?
  • Age 19+
  • Primary language is English
  • Not previously diagnosed with ADHD
  • Not a current patient of ADHD Online or Mentavi Health
  • A resident of any of the 50 US states or DC (not including Puerto Rico or other territories)
 
Why participate?
Your involvement will help improve mental health care for everyone.
 

HOLIDAY HOURS

ADHD Online will be closed on Thursday, December 25, and Friday, December 26, as well as Thursday, January 1, in observance of the holidays.

Live support will be unavailable during this time; however, you can still submit a request or leave a message. We’ll get back to you when we return.

Each of our clinicians sets their own holiday hours, check with them for their availability.

Are you looking to take our Diagnostic Evaluation? It’s available all day, every day, whenever and wherever is best for you! 

Our site is open 24/7! You can always schedule an appointment, check out our podcasts, or read up on the latest ADHD information.

Provide this form to your local practitioner. You could:

  • Send this link
  • Email the pdf
  • Print it out and bring it to your appointment

Ask your practitioner
to complete the form

In this form, your practitioner will request that ADHD Online continue to provide uninterrupted care

Return the form to us

You or your practitioner can return this form to us via email or fax it to 616-210-3118